Multi-Marker Approach in Sepsis: A Clinical Role Beyond SOFA Score
Medicina · 2026
DOI: 10.3390/medicina62010201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicina, 2026. Verfasst von Gun Hyuk Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea. Hauptthemen laut MEDLINE: Biomarkers, Sepsis. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Background and Objectives: Procalcitonin (PCT), presepsin (PSEP), interferon-λ3 (IFN-λ3), and bioactive adrenomedullin (bio-ADM) are promising sepsis biomarkers. We explored the clinical utility of a multi-marker approach using these four biomarkers in patients with suspected sepsis. Materials and Methods: In a total of 248 patients, the biomarkers were evaluated with the sequential organ failure assessment (SOFA) score. Receiver operating characteristic curves with area under the curve (AUC) were analyzed to diagnose sepsis and predict in-hospital mortality. Survival and reclassification analyses were also used to predict in-hospital mortality.
Results
The four biomarkers showed comparable diagnostic performance (AUC = 0.61–0.95, p < 0.001–0.003), and sepsis proportion increased significantly as the number of biomarkers used in the multi-marker approach increased (7.7–91.7%, p < 0.001). The proportion of biomarker quartiles (Q1–Q4) differed significantly according to SOFA score (p < 0.001). The four biomarkers predicted in-hospital mortality (AUC = 0.63–0.84, p < 0.001–0.004). The multi-marker approach performed better than the SOFA score (mortality rate, 58.3% vs. 31.3%; adjusted hazard ratio [HR], 14.7 vs. 4.6), and the addition of biomarkers to the SOFA score increased the performance. The multi-marker approach resulted in a higher HR in patients aged ≥75 years than in the overall population (9.2 vs. 4.2).
Conclusions
Each biomarker showed clinical utility in patients with suspected sepsis. The multi-marker approach showed complementary clinical utility in addition to the SOFA score and better prognostic performance in patients aged ≥75 years. The use of biomarkers, alone or in combination, would be a valuable tool in combination with the SOFA score.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
- Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul 05030, Republic of Korea.
- Department of Preventive Medicine, College of Medicine, Dong-A University, Busan 49201, Republic of Korea.
ORCID-Profile: Gun Hyuk Lee, Hanah Kim, Hee-Won Moon, Seungho Lee, Mina Hur
Zitieren
APA
Lee, G. H., Kim, H., Moon, H. W., Yun, Y. M., Lee, S., & Hur, M. (2026). Multi-Marker Approach in Sepsis: A Clinical Role Beyond SOFA Score. Medicina. https://doi.org/10.3390/medicina62010201
Vancouver
Lee GH, Kim H, Moon HW, Yun YM, Lee S, Hur M. Multi-Marker Approach in Sepsis: A Clinical Role Beyond SOFA Score. Medicina. 2026. doi:10.3390/medicina62010201
BibTeX
@article{Lee2026,
author = {Lee, Gun Hyuk and Kim, Hanah and Moon, Hee-Won and Yun, Yeo-Min and Lee, Seungho and Hur, Mina},
title = {Multi-Marker Approach in Sepsis: A Clinical Role Beyond SOFA Score},
journal = {Medicina},
year = {2026},
doi = {10.3390/medicina62010201}
}
EUVIMED